MicroCal has a 30-year history of developing and supplying easy-to-use microcalorimeters
Malvern Instruments is to buy GE Healthcare Life Sciences' MicroCal microcalorimetry business for an undisclosed sum.
The transaction, which is subject to regulatory approvals, is expected to complete in the third quarter of 2014.
MicroCal has a 30-year history of developing and supplying easy-to-use microcalorimeters for the study of proteins and other biomolecules in drug discovery and development.
Malvern said the acquisition would strengthen its expanding portfolio of analytical solutions for customers in the pharmaceutical and biopharmaceutical markets.
MicroCal will retain its key location in Northampton, Massachusetts, US and will become an integral part of the Malvern business. Paul Walker, Managing Director of Malvern Instruments, said: 'Microcalorimetry is now an essential tool that is used at almost every stage of the drug discovery, development and formulation process.
MicroCal products are an excellent fit with Malvern’s existing portfolio of measurement solutions
'MicroCal products are an excellent fit with Malvern’s existing portfolio of measurement solutions for the pharmaceutical and biopharmaceutical industries. Their ability to deliver information about drug binding and protein stability is entirely complementary to Malvern’s current products and to those in development.'
Headquartered in Malvern, UK, Malvern Instruments is a global business that serves a diverse range of academic and industrial markets, providing instrumentation for the analysis of a wide variety of materials. The company is part of the Materials Analysis Division of Spectris plc.
MicroCal differential scanning calorimeters (DSC) and isothermal titration calorimeters (ITC) are used in areas from basic research to the discovery and development of small molecules, biotherapeutics and vaccines. Customers are based in pharmaceutical, biotech, academic and government organisations around the world.